Knee Injection Treatment for Moderate Osteoarthritis
Part of Bones, joints & muscles clinical trials.
This study tests a new cell-based injection (Allocetra) directly into the knee joint for people with moderate osteoarthritis who haven't benefited from other treatments. The goal is to reduce pain and improve knee function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 64 years or older
- You have moderate knee osteoarthritis (confirmed by X-ray) in one knee that is your main focus
- You've tried at least 2 other osteoarthritis treatments that didn't work well or caused side effects
- You haven't had recent knee surgery, injury, or injection in the past few months
- You're willing to stop certain pain medications during the study and avoid specific treatments
- If you can have children, you agree to use reliable birth control during the study and for 3 months after treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new knee injection called CX-011 to see if it can reduce pain and improve function in people with knee osteoarthritis. It may be a good option if you have tried other treatments without enough relief.
This study tests the safety of an experimental injection called OA-SYS for people with moderate to severe knee osteoarthritis. It may help if you have not had recent injections or certain other health problems.
This trial tests a new injectable filler called ALLOHEAL, injected directly into the knee joint to reduce pain and improve function in people with knee osteoarthritis. The filler is designed to cushion the knee joint and may help reduce pain and stiffness.
This trial tests if a new medication called MAG200, injected into the knee, can reduce pain and improve function in people with moderate to severe knee osteoarthritis. You will receive either the study drug or a placebo (an inactive substance) to compare results.
This study tests a new investigational medicine injected into the knee to see if it is safe and tolerable for people with painful knee osteoarthritis. It may help reduce pain and improve knee function.
This study tests a new injection called Allocetra directly into the jaw joint to treat pain and inflammation in temporomandibular joint osteoarthritis. Eligible participants must have MRI-confirmed inflammation and meet basic health requirements.
Hear when a new Primary Knee Osteoarthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.